Capital 2B, a deeptech-focused fund supported by Info Edge and Temasek with participation from Capital-A and Anicut Capital, led a $2.2 million seed fundraising round for Deumas, a deeptech manufacturing business.
Leumas stated in a press release that the money will be utilized to grow its R&D capabilities, scale its on-demand manufacturing infrastructure, and start test deployments of factories specifically designed for pharmaceutical and wellness companies.
Leumas, a company co-founded in 2016 by Subhajit Biswas and Nitesh K, provides wellness and pharmaceutical brands with factory-as-a-service and on-demand manufacturing methods. The foundation of their approach is software-defined, modular robot factories that, from development to commercial production, significantly enhance manufacturing and business outcomes. Automation, software intelligence, and research and development are used to help brands scale rapidly, preserve quality, and lower risk.
Leumas claims that their primary offering is cyber-physical manufacturing technology, which consists of software-driven, modular production lines that incorporate autonomous operations, vision-based quality systems, and AI-led robotics to guarantee superior production output and regulatory compliance.
By 2030, the pharmaceutical and wellness outsourced development and manufacturing industry is projected to grow to a value of over $400 billion, according to market research.
Leumas asserts that it has co-developed its manufacturing solution with top wellness brands over the past year and has assisted in the expansion of over 120 items throughout MENA, the US, and India. Additionally, it has agreements with leading pharmaceutical and food research organizations to use its modular manufacturing technology to construct specific factory capacities.
